Short-term Effect of Glucose and Sacharose Ingestion on Cognitive Performance and Mood in Elderly

This study has been completed.
Sponsor:
Collaborator:
Suikerstichting Nederland (Baarn)
Information provided by (Responsible Party):
Lisette de Groot, Wageningen University
ClinicalTrials.gov Identifier:
NCT01427231
First received: August 26, 2011
Last updated: March 20, 2012
Last verified: March 2012

August 26, 2011
March 20, 2012
August 2011
December 2011   (final data collection date for primary outcome measure)
Performance on the paired associate recall test [ Time Frame: cognitive tests will start 15 minutes after ingestion of the intervention product ] [ Designated as safety issue: No ]
Cognitive performance will be assessed by several sensitive tests. Power is calculated on the paired associate recall test, but also several other cognitive performance test focusing on memory, attention and reaction time will be performed
Same as current
Complete list of historical versions of study NCT01427231 on ClinicalTrials.gov Archive Site
  • Mood [ Time Frame: within 15 minutes after consuming the test drink and after completing the cognitive tests (within 90 minutes after consuming the test drink) ] [ Designated as safety issue: No ]
    Mood will be measured by the POMS, after consuming the test drink, and after completing the congitive tests.
  • Blood glucose response [ Time Frame: from baseline till 90 minutes after consuming the drink ] [ Designated as safety issue: No ]
    Blood glucose will be measured at five time points, at t=0, after 15 minutes, 30, 60 and 90 minutes.
  • Plasma insulin levels [ Time Frame: At t= -15 minutes, before consuming the test drink ] [ Designated as safety issue: No ]
    One venapunction will be carried out at baseline to measure plasma insulin levels.
Same as current
Not Provided
Not Provided
 
Short-term Effect of Glucose and Sacharose Ingestion on Cognitive Performance and Mood in Elderly
The Short-term Effect of Glucose and Sacharose Ingestion on Cognitive Performance and Mood in Elderly Subjects

The objective of the current study is to determine the acute effect of a glucose drink and a sacharose drink compared to a placebo on cognitive performance in elderly with light memory complaints. The investigators expect that the sugar containing drinks will improve memory and attentional functions. Furthermore, blood glucose response will be measured.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Investigator)
  • Mental Health
  • Cognition
  • Memory
  • Attention
  • Dietary Supplement: glucose
    The effect of a glucose solution on cognitive performance will be measured.
    Other Name: Sucrose, sugar.
  • Dietary Supplement: sacharose
    The effect of a sacharose solution on cognitive performance will be measured.
  • Dietary Supplement: Placebo
    The effect of a placebo drink with sweeteners on cognitive performance will be measured.
  • Active Comparator: Drink with 50 g glucose
    The glucose drink contains 50 g of glucose soluted in 250 ml of water and lemon juice.
    Intervention: Dietary Supplement: glucose
  • Active Comparator: Drink with 100 gram of sacharose
    The sacharose drink contains 100 g of sacharose soluted in 250 ml of water and lemon juice.
    Intervention: Dietary Supplement: sacharose
  • Placebo Comparator: Placebo with sweeteners
    The placebo contains a mixture of artificial sweeteners in order to have the same sweetness and appearance of the test drinks (the glucose drink and the sacharose drink).
    Intervention: Dietary Supplement: Placebo
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
43
December 2011
December 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Men and women
  • 70 years and older
  • Memory complaints

Exclusion Criteria:

  • Type I or II diabetes
  • Parkinson disease
  • MMSE < 25 (to exclude cognitively impaired subjects
  • CES-D > 16 (to exclude depressive subjects)
  • Pharmacological antidepressives or medication for dementia
  • Liver disease
Both
70 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
Netherlands
 
NCT01427231
NL36813.081.11
Not Provided
Lisette de Groot, Wageningen University
Wageningen University
Suikerstichting Nederland (Baarn)
Not Provided
Wageningen University
March 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP